“…Allograft rejections after COVID-19 infection occurred in kidney (n = 30, 75%) [12,13,16,[46][47][48][49]53,55,57,60], cornea (n = 6, 15%) [14,15,50,56,59], lung (n = 2, 5%) [52,58], liver (n = 1, 2.5%) [54] and heart (n = 1, 2.5%) [51] transplant recipients. The most common clinical presentations in these transplant patients who presented with organ rejection post-COVID-19 infection were acute kidney injury (n = 14, 35%) [12,16,47,49,55,60], peripheral oedema (n = 6, 15%) [12,46,47,49], worsened vision (n = 6, 15%) [14,15,50,56,59], eye redness (n = 4, 10%) [14,15,56,59], reduced urine output (n = 2, 5%) [47,53], respiratory failure (n = 2, 5%) [52,58], eye discomfort (n = 2, 5%) [56,59] and conjunctivitis (n = 2, 5%)…”